Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
A Mayo Clinic-sponsored study evaluates quality of life after bladder cancer treatment across stages 0 to IIIA and is currently active but n…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC [Phase 2]
Phase 2 clinical trial evaluating intravesical gemcitabine and docetaxel for high-risk, BCG-unresponsive non-muscle-invasive bladder cancer;…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors [NA]
The update describes a trial comparing Computed Tomography Urography (CTU) to Intravenous Urography (IVU) for patients at risk of urothelial…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study [EARLY_Phase 1]
A pilot Phase 1 trial evaluating Impact Advanced Recovery for patients undergoing radical cystectomy for bladder cancer has been completed.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial [Phase 2]
Phase 2 trial evaluating whether adding pembrolizumab to radiation therapy improves outcomes for non-muscle invasive bladder urothelial carc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ARID1A and/or KDM6A Mutation and CXCL13 Expression [Phase 2]
Phase 2 clinical trial update from MD Anderson investigating ARID1A and/or KDM6A mutation status and CXCL13 expression in urothelial cancers…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating modern immunotherapy for non-muscle invasive bladder cancer (urothelial carcinoma of the bladder) in BCG…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Measuring Surgical Recovery After Radical Cystectomy
A clinical trial sponsored by MD Anderson Cancer Center is recruiting to study how surgical recovery is measured after radical cystectomy fo…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Expanded-access treatment program for the investigational gene therapy Cretostimogene Grenadanorepvec to treat non-muscle-invasive bladder c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
A clinical trial update focusing on tumor budding and T1 sub-staging in urothelial bladder cancer; recruitment is not yet started.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer [Phase 3]
Phase 3 clinical trial update evaluating eribulin plus standard chemotherapy versus standard chemotherapy alone for metastatic urothelial ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 study is testing pembrolizumab added to intravesical gemcitabine for BCG-unresponsive non-muscle invasive bladder cancer, with the…
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer [Phase 3]
A Phase 3 clinical trial is evaluating chemoradiotherapy with or without atezolizumab for localized muscle-invasive bladder cancer; the stud…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]
A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment [NA]
Clinical trial update from Umeå University studying local radiotherapy for bladder cancer in patients not eligible for curative treatment; t…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder [Phase 3]
Phase 3 study evaluating TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy for muscle-invasive bladder cancer; the …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Virtuoso Improving Anatomic Bladder Lesion Excision Trial [NA]
This document provides a status update that the Virtuoso Improving Anatomic Bladder Lesion Excision Trial is currently enrolling by invitati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy [Phase 2]
Phase 2 clinical trial evaluating the effectiveness and safety of sequential intravesical mitomycin-C and gemcitabine for bladder cancer; cu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer [Phase 1]
Phase 1 study evaluating an intravesical delivery system of erdafitinib in Japanese patients with bladder cancer.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas [Phase 1]
Phase 1 study evaluating safety, efficacy, and pharmacokinetics of EVOLVE104 in patients with advanced urothelial cancer and squamous cell c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer [NA]
This clinical trial examines using FAPI and FDG PET/MRI imaging to diagnose bladder cancer and predict response to therapy.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
A ClinicalTrials.gov entry describes a study evaluating the immune-stromal landscape in muscle-invasive bladder cancer, sponsored by Assiut …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.